Have a website account?
Log In
or
Register
for exclusive website content.
Subscribe
Advanced Search
Home
Journal Info
About
tau
Indexing
Editors-in-Chief
Editorial Board
Former Editorial Board
Peer Review Process
Supplements and Series
Advertising Policy
News
Testimonials
For Authors
Author Instructions
Online Submission
Submit Multimedia Files
Reference Style
AME Editing Service
Interviews with Outstanding Authors
For Reviewers
Guidelines for Reviewers
Online Review
Reviewers
Ethics and Policies
Journal Management (Editorial Roles)
Editorial Policies
Publication Ethics Policy
Research Ethics Policy
Human and Animal Rights
Authorship and Contributorship
Informed Consent Policy
Conflicts of Interest
Data Sharing Policy
Open Access Statement
Content Licensing
Copyright and Permission
Quality Control System
Data and Reproducibility
Policy of Screening for Plagiarism Process
Policy of Dealing with Allegations of Research Misconduct
Corrections and Retractions
Complaints and Appeals
Special Contents
Special Series (Published)
Special Series (Ongoing)
Surgical Videos
Interviews with Guest Editors
Archives
Online First
Article Processing Charges
Home
/
Vol 4, Supplement 1 (August 30, 2015): Translational Andrology and Urology
/
AB085. Immune therapy: new option for prostate cancer
Podium Lecture
AB085. Immune therapy: new option for prostate cancer
Wei Wang, Shan Chen
Article Options
ABSTRACT
996 views
Download Citation
Bibtex
EndNote
ProCite
refMan
refWorks
Share
Share on Facebook
Share on Twitter
